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Trihalomethanes as Initiators and
Promoters of Carcinogenesis
by Michael A. Pereira,* Luan-Ho C. Lin,*
John M. Lippitt* and Sydna L. Herren*
Chloroform and other trihalomethanes are contaminants of drinking water that have been
demonstrated to be carcinogenic in laboratory animals. Determination of the mechanism of
carcinogenicity ofchloroform is required so that the animal data can be extrapolated to estimate
the human health hazard. The extent ofthe binding of chloroform to rat liver and kidney DNA
was approximately 0.1% the level ofbinding found for dimethylnitrosamine. Neither chloroform
nor bromoform, in contrast to diethylnitrosamine-initiated GGTase-positive foci in either intact
or partial hepatectomized rats, promoted with phenobarbital. Tumor-promoting activity of
chloroform was indicated by the slight significant increase, compared to untreated controls, in
the incidence ofGGTase-positive foci in rats initiated with diethylnitrosamine (DENA) followed
by the administration of chloroform twice weekly for a total of 15 doses. In this study, rats
administered only the DENA or the chloroform did not contain an increased incidence of
GGTase-positive foci compared to untreated controls. However, the incidence offoci inthe group
thatreceived DENAfollowed by chloroform was not statistically different from that in eitherthe
group that received only the DENA or only the chloroform. In conclusion, we were unable to
demonstrate tumor-initiating activity for chloroform, and the tumor-promoting activity of
chloroform indicated by our results requires further confirmation.
Introduction
The chlorination ofdrinking water can represent
a major exposure to humans of trihalomethanes
including bromoform and chloroform (1-3). Chloro-
form induced hepatocellular carcinomas and kidney
epithelial tumors in mice and rats, respectively (4).
The extrapolation of these results from animals to
the estimation ofthe carcinogenic risk in humans of
chloroform in drinking water requires the determi-
nation of the mechanism of action for chloroform
carcinogenicity.
Chemicals can increase the incidence of cancerby
two distinct mechanisms: genetic and epigenetic
(5,6). The proposed genetic mechanism ofchemical
carcinogenesis results from the covalent reaction of
the carcinogen with DNA. This alteration could
produce a somatic mutation resulting in the forma-
tion of a clone (focus) of transformed cells. Thus
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genetic carcinogens initiate the neoplastic progres-
sion. The othermechanism ofaction forcarcinogens
is epigenetic and involves an alteration in the
control of cellular differentiation and replication.
Tumor promoters are epigenetic carcinogens that
decrease the time required for the appearance and
increase the incidence of tumors that were either
spontaneously or chemically initiated. Some carcin-
ogens act by both genetic and epigenetic mecha-
nisms. In this paper, we have attempted to deter-
mine whether chloroform increased theincidence of
cancer in the NCI bioassay by genetic, epigenetic
or both mechanisms.
Materials and Methods
Animals and Chemicals
Male (225 to 275 g) Sprague-Dawley rats and
female B6C3/F1 mice (8 to 9 weeks old) were pur-
chased from Charles River (Portage, Mich.) and
used throughout these studies. The animals were
maintained in accordance with the standards set152
forth by the National Research Council (7). Unless
otherwise noted, Purina Laboratory Chow (Ralston
Purina Co., St. Louis, Mo.) and distilled water
were provided ad libitum.
Chloroform(glass-distilled, nonpreservative)was
purchased from Burdick andJackson Laboratories,
Inc. (Muskegon, Mich.), bromoform from Tridom
ChemicalCo. (Hauppauge, N.Y.), diethylnitrosamine
(DENA) from Eastman Kodak Co., (Rochester,
N.Y.), sodium barbital from Fisher Scientific Co.
(Pittsburgh, Pa.), sodium phenobarbital from J.T.
Baker Chemical Co. (Phillipsburg, N. J.) and Trica-
prylin from ICN Nutritional Biochemicals (Cleve-
land, Oh.).
DNA Binding
Groups ofmice and rats were administered intra-
gastrically bromoform-14C (2.7 mCi/mmole, ICN
Pharmaceutical, Inc., Irvine, Calif.), orchloroform14C
(15 mCi/mmole, ICN Pharmaceutical, Inc., Irvine,
Calif.)dissolvedin cornoil ordimethylnitrosamine-'4C
(50.9 mCi/mmole, New England Nuclear, Boston,
Mass.) in saline. The animals were sacrificed by
cervical dislocation 16-18 hr later for the trihalo-
methanes and after 2 hr for dimethylnitrosamine
(DMN). The liver and kidney were excised and
stored at -80°C until the DNA was isolated.
DNA was isolated fromthe liverby amodification
of the procedure described by Kirby (8). The liver
was homogenized in a lysingmedium containing 1%
sodiumtriisopropylnaphthalenesulfonate, 6%isobut-
anol, 6% sodiump-aminosalicylate, 1% sodium chlo-
ride and 0.01% sodium deoxycholate and incubated
with proteinase K for 1 hr. After extraction with
Kirby's phenol solution, the DNA was precipitated
with 2-ethoxyethanol. The DNA was then sequen-
tially treated with RNase, a-amylase and pronase
followed by a second phenol extraction. After pre-
cipitation with 2-ethoxyethanol, the DNA was dis-
solved in water. For determination ofradioactivity,
an aliquot ofthe DNA was hydrolyzed in 0.1N HCI
at 70°C for 30 min, dissolved in ACS (American
Corp., Arlington Heights, Ill.) and counted in a
Beckman 9000 liquid scintillation counter (Beckman
Instrument Co., Palo Alto, Calif.). DNA concentra-
tion was determined by the procedure of Kissane
and Robins (9).
The DNA was further purified by CsCl isopyknic
centrifugation. The DNA was dissolved in 1.3 ml of
a 0.25% SDS solution and layered onto a 3.5 ml
CsCl solution of an average density of 1.80 g/cm3 so
that the final average density was 1.59 g/cm3. Cen-
trifugation was performed in a Beckman SW 50.1
rotor(Becknan Instrument Co., PaloAlto) at35,000
rpm and for 65 hr. Fractions were collected by
puncturing the bottom of the centrifuge tube and
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were monitored forradioactivity, absorbance at260
nm and density.
In attempts to isolate the adducts of chloroform
covalently bound to DNA, the DNA was hydro-
lyzed in 0.1N HCI at 70°C for 30 min. The hydroly-
zate was chromatographed on a high performance
liquid chromatograph equipped with a semiprepar-
ative Partisil 10 SCX ion-exchange column (What-
man Inc., Clifton, N.J.). Elution was accomplished
at a flow rate of 4 ml/min with 0.025M ammonium
phosphate (pH 4.0) for 20 min, followed by a linear
increase over 20 min in the concentration so that
the final concentration was 0.25M ammonium phos-
phate (pH 4.0).
Initiation Assay
The rat liver foci bioassay (10-12) was used to
distinguish the initiation and promotion activity of
trihalomethanes. The protocols ofthe initiation and
promotion assays are depicted in Figure 1. For the
initiation assay, male rats received a 2/3 partial
hepatectomywhileunderetheranesthesia. At20-22
hr later, the rats were administered by gavage
bromoform (0.8 mmole/kg body weight) or chloro-
form (1.5 mmole/kg body weight) in tricaprylin or
diethylnitrosamine (0.5 mmole/kg body weight) in
distilledwater. Thechemicalsadministeredbygavage
were given as 2 mi/kg body weight. Three days
later, the rats started to receive 500 ppm sodium
phenobarbital in their drinking water for a total of
47 days. Six days after the termination of the
phenobarbitaltreatmenttheanimalsweresacrificed
by decapitation and the right lateral liver lobe
quickly excised. Four tissue blocks, each approxi-
mately 10 x 10 x 2 mm, were taken and frozen in
O.C.T. compound(FisherScientificCo., Pittsburgh,
Pa.) on dry ice. The slices were arranged so that
the leading face of each block was not serially
related to the leading face of another block. The
tissue blocks were stored at -80°C until being sliced
at -25°C into 6 ,um sections. The sections were
stained by the procedure of Rutenburg et al. (13)
for-y-glutamyltranspeptidase(GGTase)activityand
counterstained with hematoxylin. GGTase-positive
foci that contained nine or more nuclei were count-
ed. From each animal at least 2 cm2 oftissue were
scanned for foci. An increase incidence of GGTase-
positive foci was indicative ofcarcinogenic activity.
Promotion Assay
Male rats were administered by gavage an ini-
tiating dose of diethylnitrosamine (0.5 mmole/kg
bodyweight) indistilledwater(2ml/kgbodyweight).
Three days later, some of the rats received intra-
gastrically chloroform (1.5 mmole/kg body weight)CARCINOGENICITY OF TRIHALOMETHANES
RAT LIVER FOCI BIOASSAY PROTOCOL
A. INITIATION ASSAY
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FIGURE L Schematic presentation of the initiation and
promotion protocols of the rat liver foci bioassay.
in tricaprylin (2 ml/kgbodyweight) ortricaprylin (2
ml/kg body weight) twice weekly for a total of 53
days. Other rats received 500 ppm sodium barbital
in their drinking water for the same length oftime
(positive control). Four to five days afterthe termi-
nation of the promotion regimens, the rats were
sacrificed. Their liver were excised and scored for
GGTase-positive foci as described above.
Results
DNA Binding
The DNA isolated by the phenol extraction pro-
cedure, even though it contained less than 3% pro-
tein, required further purification in order to de-
monstrate thatthe radioactivity wasbound to DNA
and not to the contaminating protein. Cesium chlo-
ride isopyknic centrifugation was used to further
purify the liver and kidney DNA from the rats
treated with either bromoform-14C (1.5 mmole/kg
body weight, 2.7 mCi/mmole), chloroform-14C (0.4
mmole/kgbodyweight, 15mCi/mmole), orDMN-14C
(0.1 mmole/kg body weight, 50.9 mCi/mmole) and
from the liver of mice treated with chloroform-14C
(1 mmole/kg body weight, 15 mCi/mmole). In rat
liver and kidney, a definite peak of radioactivity
derived from chloroform was found associated with
theultraviolet-absorbing peakcontainingthe DNA,
whereas no association was found for chloroform in
mouse liverand bromoformin ratliver(Fig. 2). The
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binding index of chloroform to rat liver and kidney
DNA was 0.017 and 0.0055, respectively, which
represents 0.05-0.15% the binding index for DMN
(11.4, Table 1).
The radioactivity present in kidney DNA from
rats treated with chloroform-14C was demonstrated
to represent the formation ofadducts in contrast to
incorporation during de novo DNA synthesis (Fig.
3). The kidney DNA was hydrolyzed in 0.iN HCl
and the hydrolyzate chromatographed on a HPLC
equipped with a semipreparative Partisil 10 SCX
ion exchange column. Over 95% of the applied
radioactivity was eluted in the early peak contain-
ing the pyrimidines and deoxyribosyl phosphate
backbone of the DNA. There was no evidence for
the incorporation of radioactivity into adenine and
guanine. Since over 60% of the radioactivity was
Previously demonstrated to be bound to the DNA
(Fig. 2C), it was unlikely that the radioactivity in
the early peak represented contaminating protein
or incorporation by de novo synthesis of the DNA
constituentswithexclusionofthepurines. Therefore,
chloroformappearedtobindDNAatthepyrimidines,
or phosphate and/or to form dinucleotide linkage.
Initiation Assay
Bromoform (0.8mmole/kgbodyweight) and chlo-
roform (1.5 mmole/kg body weight) were tested in
the initiation protocol of the rat liver foci bioassay
(Fig. 1). The trihalomethanes did not increase the
incidenceofGGTase-positive fociwhenadministered
toeitherintactorpartialhepatectomizedrats(Table
2). DENA (0.5 mmole/kg bodyweight), the positive
control, resulted in the expected positive response.
The initiating activity, if any, of trihalomethanes
was much less than DENA.
Promotion Assay
The promoting activity of chloroform was deter-
mined in the promotion protocol ofthe rat liver foci
bioassay (Fig. 1). Chloroform (1.5 mmole/kg body
weight) administered twice weekly for 53 days to
non-initiated rats or DENA administered to non-
promoted rats did not result in a statistically
significant increased incidence of GGTase-positive
foci (Table 3). A slight but significant increase in
the incidence of GGTase-positive foci compared to
untreated controlswasobservedinratsthatreceived
the initiating dose ofDENAfollowed bythe chloro-
form promotion regimen. The incidence of GGTase-
positive foci in animals initiated with DENA and
promoted with chloroform was not significantly dif-
ferent from the incidence in animals treated either
only with DENA or with chloroform.PEREIRA ET AL.
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FIGURE 2. Cesium chloride isopyknic centrifugation of DNA. The DNA was dissolved in 0.25% SDS and layered on a CsCl solution
(1.80 g/cm3) so that the final density was 1.59 g/cm3. Centrifugation was performed in a Beckman SW 50.1 rotor at 35,0000 rpm
for 65 hr. Fractions were collected by puncturing the bottom ofthe centrifuge tube and were monitored for ( ) radioactivity
(dpm) (-) absorbance at 260 nm and density: (A) liver DNA from bromoform treated rats, amount applied 1.3 mg, and 1990 dpm;
(B) liver DNA from chloroform-treated rats, amount applied 0.46 mgand 1475 dpm; (C) kidney DNA from chloroform-treated rats,
amount applied 2.9 mg and 438 dpm; (D) liver DNA from chloroform-treated mice, amount applied 2.8 mg and 875 dpm;
(E) liver DNA from dimethylnitrosamine-treated rats, amount applied 0.32 mg and 1890 dpm.
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Table 1. Binding of trihalomethanes to DNA.
Binding index
Chemical Species Organ CsCla
Chloroform Rat Liver 0.017
Rat Kidney 0.0055
Mouse Liver < 0.0012
Bromoform Rat Liver < 0.015
DMNb Rat Liver 11.4
aBinding index = pmole bound per mg DNA/,umole kg body
weight.
bDMN = dimethylnitrosamine.
Discussion
Chloroform is an environmental carcinogen found
in drinking water (3,4). Estimation of the human
health hazard as a consequence of this exposure to
chloroform requires extrapolation ofthe animalcar-
cinogenicity datatohumans. Models fortheextrapo-
lation of animal data to humans are being devel-
oped. Two possible mechanisms of action for the
carcinogenicity ofchloroform are genetic (initiation)
and/orepigenetic (promotion). The determination of
the contribution ofthese two mechanisms ofaction
to the carcinogenicity of chloroform is required
prior to the adaptation ofthe appropriate extrapo-
lation model.
The possible initiating activity ofchloroform was
investigated by determination of the binding to
DNA and the ability to initiate an increased inci-
dence of GGTase-positive foci in the rat liver foci
bioassay (10-12). Chloroform was demonstrated to
bind rat liver and kidney DNA but there was no
evidence forbindingto mouse liver DNAwithinthe
sensitivity ofthe assay. The total binding ofchloro-
form or bromoform to rate liver or kidney DNA
was less than 0.15% the binding ofDMN torat liver
DNA. The low level ofDNA binding by bromoform
and chloroform indicated that the contribution of
the genetic or initiating component to the carcino-
genicity ofthe trihalomethanes was much less than
the genetic component ofDMN. In the rat liver foci
bioassay forinitiatingactivity, bromoform and chlo-
roform when administrated to either partial hepa-
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FIGURE 3. HPLC elution profile of acid-hydrolyzed
DNA. Kidney DNA from chloroform treated rats
was hydrolyzed in 0.1N HCl at 70°C for 30 min. The
hydrolyzate was applied to a high performance liquid
chromatograph equipped with a semipreparative
Partisil 10 SCX ion exchange column. The column
was eluted at a flow rate of 4 ml/min with 0.025M
ammonium phosphate (pH 4.0) for 20 min, followed
by a linear increase over 20 min in the concentration
to 0.25M ammonium phosphate (pH 4.0). The eluate
was monitored for absorbance at 260 nm and 2 ml
fractions collected for determination of radioactivity.
Table 2. Initiation assay of trihalomethanes.
Treatment
Group N Initiation Partialhepatectomy Promotiona GGTase foci, foci/cm2
A 12 Chloroform + + 1.08 0.28b
B 12 Chloroform - + 0.40 ± 0.21
C 12 Bromoform + + 0.48 ± 0.12
D 12 Bromoform - + 0.26 + 0.18
E 12 Tricaprylin + + 1.07 ± 0.24
F 12 Tricaprylin - + 0.13 ± 0.07
G 12 DENA + + 15.8 ± 1.9
aPromotion was accomplished with 500 ppm sodium phenobarbital in drinking water for 47 days.
bResults are means ± standard errors.
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Table 3. Promotion assay of chloroform.
Treatment Weight, g' Organ body GGTase foci,
Group N Initiation Promotion Body Liver weight x 100a foci/cm2a
A 15 Water Tricaprylin 498 ± 12b 15.1 ± 0.5 3.0 ± 0.06 0.45 ± 0.14
B 16 DENA Tricaprylin 497 ± 10 15.4 ± 0.5 3.0 ± 0.13 0.90 ± 0.31
C 15 Water Chloroform 466 ± 8.6 15.0 ± 0.5 3.2 ± 0.05 1.42 ± 0.44
D 16 DENA Chloroform 466 ± 9.4 14.6 ± 0.5 3.1 ± 0.08 2.22 ± 0.63c
E 10 DENA Barbital 3.02 ± 1.10c
aResults are means ± standard errors.
'The initial body weights ofthe groups were 260-268.
cDifferent from group A by a nonparametric test with p < 0.05.
tectomized orintact rats and followed by promotion
with phenobarbital did not initiate GGTase-positive
foci. Initiation of GGTase-positive foci was demon-
strated for DENA (the positive control). The low
levelofDNAbindingandthefailureto demonstrate
initiatingactivityintheratliverfocibioassay would
indicate that any initiating activity ofchloroform is
substantially lower than nitrosamines.
Chloroform is toxic to the liver and kidney (14,
15) which are the target organs ofcarcinogenesis in
rodents. The hepatic response to chloroform in rats
included regenerative hyperplasia (16) and induc-
tion of ornithine carboxylase (17). Regenerative
hyperplasia and induction of ornithine decarboxyl-
ase are properties possessed by hepatic tumor
promoters (18, 19). We attempted to obtain evi-
dence in the rat liver foci bioassay for the tumor
promoting activity of chloroform. in rats initiated
with DENA, subsequent treatment with chloro-
form increased the incidence of GGTase-positive
foci when compared to untreated rats. However,
when compared to rats that received only the
DENA orchloroform the increased incidence offoci
was not significant. Therefore, further confirma-
tory studies are required to demonstrate the tumor
promoting activity of chloroform. In summary,
chloroform would appear to possess (1) very little if
anytumor-initiatingactivity and(2)asyetunproven
tumor-promoting activity.
The authors sincerely appreciate the excellent technical help
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